Oruka Therapeutics, Inc. — Revenue by Fiscal Year
11 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/3dadccc4-278d-484c-adf2-c282b5862150/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2023 | $0 | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-009809 |
| FY 2022 | $0 | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-004379 |
| FY 2021 | $0 | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-010075 |
| FY 2020 | $0 | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-014148 |
| FY 2019 | $0 | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-005032 |
| FY 2018 | $0 | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-004882 |
| FY 2017 | $0 | 2017-01-01 – 2017-12-31 | evidence 0001564590-18-006566 |
| FY 2016 | $0 | 2016-01-01 – 2016-12-31 | evidence 0001564590-17-004897 |
| FY 2015 | $0 | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-014989 |
| FY 2014 | $0 | 2014-01-01 – 2014-12-31 | evidence 0001564590-15-001840 |
| FY 2013 | $0 | 2002-01-01 – 2013-09-30 | evidence 0001564590-13-001316 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Oruka Therapeutics, Inc. — all facts · Net Income · Operating Income